<VariationArchive VariationID="3245828" VariationName="NC_000007.13:g.(?_107542163)_(107559704_?)del" VariationType="Deletion" Accession="VCV003245828" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3405488" VariationID="3245828">
      <GeneList>
        <Gene Symbol="DLD" FullName="dihydrolipoamide dehydrogenase" GeneID="1738" HGNC_ID="HGNC:2898" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="107891107" stop="107921198" display_start="107891107" display_stop="107921198" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="107531585" stop="107561642" display_start="107531585" display_stop="107561642" Strand="+" />
          </Location>
          <OMIM>238331</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000007.13:g.(?_107542163)_(107559704_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" innerStart="107542163" innerStop="107559704" display_start="107542163" display_stop="107559704" variantLength="17542" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.(?_107542163)_(107559704_?)del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.(?_107542163)_(107559704_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000007.13:g.(?_107542163)_(107559704_?)del AND Pyruvate dehydrogenase E3 deficiency" Accession="RCV004583589" Version="1">
        <ClassifiedConditionList TraitSetID="3242">
          <ClassifiedCondition DB="MedGen" ID="C5574660">Pyruvate dehydrogenase E3 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10448086</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17404228</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21558426</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21930696</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21996136</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23995961</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27544700</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3242" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9028" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency, lactic acidosis due to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0013" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DLD DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">E3 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase (E3) Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maple syrup urine disease, type 3</ElementValue>
                <XRef ID="Maple+syrup+urine+disease+type+1B/4456" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase E3 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyruvate dehydrogenase E3 deficiency</ElementValue>
                <XRef ID="MONDO:0009529" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MAPLE SYRUP URINE DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MSUD3</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DLDD</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3263" />
                <XRef ID="3263" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypes of dihydrolipoamide dehydrogenase (DLD) deficiency are an overlapping continuum that ranges from early-onset neurologic manifestations to adult-onset liver involvement and, rarely, a myopathic presentation. Early-onset DLD deficiency typically manifests in infancy as hypotonia with lactic acidosis. Affected infants frequently do not survive their initial metabolic decompensation, or die within the first few years of life during a recurrent metabolic decompensation. Children who live beyond the first two to three years frequently exhibit growth deficiencies and residual neurologic deficits (intellectual disability, spasticity, ataxia, and seizures). In contrast, isolated liver involvement can present as early as the neonatal period and as late as the third decade. Evidence of liver injury/failure is preceded by nausea and emesis and frequently associated with encephalopathy and/or coagulopathy. Acute metabolic episodes are frequently associated with lactate elevations, hyperammonemia, and hepatomegaly. With resolution of the acute episodes affected individuals frequently return to baseline with no residual neurologic deficit or intellectual disability. Liver failure can result in death, even in those with late-onset disease. Individuals with the myopathic presentation may experience muscle cramps, weakness, and an elevated creatine kinase.</Attribute>
                <XRef ID="NBK220444" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25032271</ID>
                <ID Source="BookShelf">NBK220444</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="2394" DB="Orphanet" />
              <XRef ID="765" DB="Orphanet" />
              <XRef ID="C5574660" DB="MedGen" />
              <XRef ID="MONDO:0009529" DB="MONDO" />
              <XRef Type="MIM" ID="246900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9836359" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000007.13:g.(?_107542163)_(107559704_?)del|MedGen:CN043137" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005065973" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10448086</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17404228</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21558426</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21930696</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21996136</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23995961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27544700</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DLD protein in which other variant(s) (p.Asp479Val) have been determined to be pathogenic (PMID: 10448086, 17404228, 21558426, 21930696, 21996136, 23995961, 27544700). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is a gross deletion of the genomic region encompassing exon(s) 3-14 of the DLD gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with DLD-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.(?_107542163)_(107559704_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043137" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9836359" TraitType="Disease" MappingType="XRef" MappingValue="CN043137" MappingRef="MedGen">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

